Sphera Funds Management Ltd. Lava Therapeutics Nv Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 146,457 shares of LVTX stock, worth $146,457. This represents 0.04% of its overall portfolio holdings.
Number of Shares
146,457
Previous 367,582
60.16%
Holding current value
$146,457
Previous $661,000
63.24%
% of portfolio
0.04%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding LVTX
# of Institutions
28Shares Held
3.61MCall Options Held
32.9KPut Options Held
500-
Redmile Group, LLC San Francisco, CA2.07MShares$2.07 Million0.23% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$771,8740.53% of portfolio
-
Two Sigma Investments, LP New York, NY103KShares$102,7660.0% of portfolio
-
Pathway Financial Advisors LLC103KShares$102,5000.04% of portfolio
-
Alpha Wave Global, LP New York, NY87.4KShares$87,3970.07% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $25.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...